Neurocognitive endophenotypes of impulsivity and compulsivity: Towards dimensional psychiatry

Trends in Cognitive Sciences

Volumn 16, Issue 1, 2012, Pages 81-91

  Robbins, Trevor W ^a,b   Gillan, Claire M ^a,b   Smith, Dana G ^a,b   de Wit, Sanne ^d   Ersche, Karen D ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b University of Cambridge   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL APPROACH; COGNITIVE PROCESS; DIAGNOSTIC TOOLS; EATING DISORDERS; MENTAL HEALTH; NEURAL SYSTEMS; OBSESSIVE-COMPULSIVE DISORDERS; PSYCHIATRIC DISORDERS;

BEHAVIORAL RESEARCH;

COGNITIVE SYSTEMS;

ATTENTION DEFICIT DISORDER; COGNITION; COMORBIDITY; COMPULSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DEPENDENCE; EATING DISORDER; ENDOPHENOTYPE; HUMAN; IMPULSIVENESS; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PSYCHIATRY; REVIEW; SUBSTANCE ABUSE;

BIOLOGICAL PSYCHIATRY; COMPULSIVE BEHAVIOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EATING DISORDERS; ENDOPHENOTYPES; HUMANS; IMPULSIVE BEHAVIOR; NEUROBIOLOGY; OBSESSIVE-COMPULSIVE DISORDER; SUBSTANCE-RELATED DISORDERS;

EID: 84855338277     PISSN: 13646613     EISSN: 1879307X     Source Type: Journal    
DOI: 10.1016/j.tics.2011.11.009     Document Type: Review

References (100)

1. Sahakian B.J., et al. A UK strategy for mental health and wellbeing. Lancet 2010, 375:1854-1855.
2. McHugh P.R. Striving for coherence: psychiatry's efforts over classification. JAMA 2005, 293:2526-2528.
3. Conn P.J., Roth B.L. Opportunities and challenges of psychiatric drug discovery. Neuropsychopharmacology 2008, 33:2048-2060.
4. Gottesman I.I., Shields J. Genetic theorizing and schizophrenia. Br. J. Psychiatry 1973, 122:15-30.
5. Meyer-Lindenberg A., Weinberger D.R. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat. Rev. Neurosci. 2006, 7:818-827.
6. Flint J., Munafò M.R. The endophenotype concept in psychiatric genetics. Psychol. Med. 2006, 37:163-180.
7. Corlett P.R., et al. Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity and psychosis. Arch. Gen. Psychiatry 2006, 63:611-621.
8. Daruna J.H., Barnes P.A. A neurodevelopmental view of impulsivity and its relationship to the superfactors of personality. The impulsive client: theory, research and treatment 1993, American Psychological Association. W.G. McCown (Ed.).
9. The Oxford handbook of impulse control disorders 2012, Oxford University Press. J.E. Grant, M.N. Potenza (Eds.).
10. Dalley J.W., et al. Impulsivity, compulsivity, and top-down cognitive control. Neuron 2011, 69:680-694.
11. Logan G.D., et al. Impulsivity and inhibitory control. Psychol. Sci. 1997, 8:60-64.
12. Kirby K.N., Petry N.M. Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drug-using controls. Addiction 2004, 99:461-471.
13. Goodman W.K., et al. The Yale-Brown Obsessive Compulsive Scale 1. Development, Use, and Reliability. Arch. Gen. Psychiatry 1989, 46:1006-1011.
14. Franken I.H.A., et al. Initial validation of two opiate craving questionnaires: the Obsessive Compulsive Drug Use Scale and the Desires for Drug Questionnaire. Addict. Behav. 2002, 27:675-685.
15. Clarke H.F., et al. Lesions of the medial striatum in monkeys produce perseverative impairments during reversal learning similar to those produced by lesions of the orbitofrontal cortex. J. Neurosci. 2008, 28:10972-10982.
16. Patton J.H., et al. Factor structure of the Barratt Impulsiveness Scale. J. Clin. Psychol. 1995, 51:768-774.
17. Leckman J.F., et al. Symptom dimensions in obsessive-compulsive disorder: implications for the DSM-V. CNS Spectr. 2007, 12:376-387.
18. Watkins L.H.A., et al. Executive function in Tourette's syndrome and obsessive-compulsive disorder. Psychol. Med. 2005, 35:571-582.
19. Phillips K.A., et al. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?. Depress. Anxiety 2010, 27:528-555.
20. Rachman S., de Silva P. Abnormal and normal obsessions. Behav. Res. Ther. 1978, 16:233-248.
21. Menzies L., et al. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofrontal-striatal model revisited. Neurosci. Biobehav. Rev. 2008, 32:525-549.
22. Meunier D., et al. Brain functional connectivity in stimulant drug dependence and obsessive-compulsive disorder. Neuroimage 2012, 59:1461-1468.
23. Evans D.W., et al. The role of the orbitofrontal cortex in normally developing compulsive-like behaviors and obsessive-compulsive disorder. Brain Cogn. 2004, 55:220-234.
24. Gillan C.M., et al. Disruption in the balance between goal-directed behaviour and habit learning in obsessive-compulsive disorder. Am. J. Psychiatry 2011, 168:718-726.
25. Lovibond P.F., et al. Safety behaviours preserve threat beliefs: protection from extinction of human fear conditioning by an avoidance response. Behav. Res. Ther. 2009, 47:716-720.
26. Bienvenu O.J., et al. Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychol. Med. 2011, 13:1-13.
27. Nakatani E., et al. Children with very early onset obsessive-compulsive disorder: clinical features and treatment outcome. J. Child Psychol. Psychiatry 2011, 52:1261-1268.
28. Taylor S. Early versus late onset obsessive-compulsive disorder: evidence for distinct subtypes. Clin. Psychol. Rev. 2011, 31:1083-1100.
29. Singer H.S. Treatment of tics and tourette syndrome. Curr. Treat. Options Neurol. 2010, 12:539-561.
30. Koran L.M., et al. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am. J. Psychiatry 2007, 164:5-53.
31. Bloch M.H., et al. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol. Psychiatry 2006, 11:622-632.
32. Piancentini J., et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA 2010, 303:1929-1937.
33. Menzies L., et al. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain 2007, 130:3223-3236.
34. Saxena S., et al. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br. J. Psychiatry 1998, 173:26-37.
35. Stern E., et al. A functional neuroanatomy of tics in Tourette syndrome. Arch. Gen. Psychiatry 2000, 57:741-748.
36. Cavedini P., et al. Executive dysfunctions in obsessive-compulsive patients and unaffected relatives: searching for a new intermediate phenotype. Biol. Psychiatry 2010, 67:1178-1184.
37. Chamberlain S.R., et al. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am. J. Psychiatry 2006, 163:1282-1284.
38. Chamberlain S.R., et al. Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am. J. Psychiatry 2007, 164:335-338.
39. Chamberlain S.R., et al. Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science 2008, 321:421-422.
40. Lipszyc J., Schachar R. Inhibitory control and psychopathology: a meta-analysis of studies using the stop signal task. J. Int. Neuropsychol. Soc. 2010, 16:1064-1076.
41. Ersche K.D., et al. Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biol. Psychiatry 2010, 68:770-773.
42. Hogarth L., et al. Impaired goal-directed behavioural control in human impulsivity. Q. J. Exp. Psychol. 2011, 10.1080/17470218.2010.518242.
43. Everitt B.J., Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 2005, 8:1481-1489.
44. Robinson E.S.J., et al. Behavioural characterisation of high impulsivity on the 5-choice serial reaction time task: specific deficits in 'waiting' versus 'stopping'. Behav. Brain Res. 2009, 196:310-316.
45. Winstanley C.A., et al. Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin. Psychol. Rev. 2006, 26:379-395.
46. Perry J.L., Carroll M.E. The role of impulsive behavior in drug abuse. Psychopharmacology 2008, 200:1-26.
47. Ersche, K.D. et al. (2011) Abnormal brain structure predisposing to stimulant drug addiction. Science in press.
48. Silveri M.M., et al. Adolescents at risk for alcohol abuse demonstrate altered frontal lobe activation during stroop performance. Alcohol. Clin. Exp. Res. 2011, 35:218-228.
49. Ersche K.D., et al. Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain 2011, 134:2013-2024.
50. Brook D.W., et al. Association between attention-deficit/hyperactivity disorder in adolescence and substance use disorders in adulthood. Arch. Pediatr. Adolesc. Med. 2010, 164:930-934.
51. Solanto M.V., et al. The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: a supplement to the NIMH multimodal treatment study of AD/HD. J. Abnorm. Child Psychol. 2001, 29:215-228.
52. Sonuga-Barke E.J. The dual pathway model of AD/HD: an elaboration of neurodevelopmental characteristics. Neurosci. Biobehav. Rev. 2003, 27:593-604.
53. 2 receptor binding in obsessive-compulsive disorder. Biol. Psychiatry 2004, 55:1041-1045.
54. Franklin T.R., et al. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol. Psychiatry 2002, 51:134-142.
55. 2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am. J. Psychiatry 2001, 158:2015-2021.
56. Fals-Stewart W., Angarano K. Obsessive-compulsive disorder among patients entering substance-abuse treatment - prevalence and accuracy of diagnosis. J. Nerv. Ment. Dis. 1994, 182:715-719.
57. Burns G.L., et al. Revision of the Padua Inventory of obsessive compulsive disorder symptoms: Distinctions between worry, obsessions, and compulsions. Behav. Res. Ther. 1996, 34:163-173.
58. Ersche K.D., et al. Response perseveration in stimulant dependence is associated with striatal dysfunction and can be ameliorated by a D(2/3) receptor agonist. Biol. Psychiatry 2011, 70:754-762.
59. Davis C., Carter J.C. Compulsive overeating as an addiction disorder. A review of theory and evidence. Appetite 2009, 53:1-8.
60. Volkow N.D., Wise R.A. How can drug addiction help us understand obesity?. Nat. Neurosci. 2005, 8:555-560.
61. Pelchat M.L. Of human bondage: food craving, obsession, compulsion, and addiction. Physiol. Behav. 2002, 76:347-352.
62. Halford J.C., et al. Effect of television advertisements for foods on food consumption in children. Appetite 2004, 42:221-225.
63. Barry D., et al. Obesity and its relationship to addictions: is overeating a form of addictive behavior?. Am. J. Addict. 2009, 18:439-451.
64. Cowan J., Devine C. Food, eating, and weight concerns of men in recovery from substance addiction. Appetite 2008, 50:33-42.
65. Avena N.M., et al. Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci. Biobehav. Rev. 2008, 32:20-39.
66. Volkow N.D., et al. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2008, 363:3191-3200.
67. Wang G.J., et al. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: A concept review. J. Addict. Dis. 2004, 23:39-53.
68. Dawe S., Loxton N.J. The role of impulsivity in the development of substance use and eating disorders. Neurosci. Biobehav. Rev. 2004, 28:343-351.
69. Galanti K., et al. Test meal intake in obese binge eaters in relation to impulsivity and compulsivity. Int. J. Eat. Dis. 2007, 40:727-732.
70. Nederkoorn C., et al. Why obese children cannot resist food: the role of impulsivity. Eat. Behav. 2006, 7:315-322.
71. Maayan L., et al. Disinhibited eating in obese adolescents is associated with orbitofrontal volume reductions and executive dysfunction. Obesity 2011, 19:1382-1387.
72. Pannacciulli N., et al. Brain abnormalities in human obesity: a voxel-based morphometric study. Neuroimage 2006, 31:1419-1425.
73. Volkow N.D., et al. Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity 2009, 17:60-65.
74. Schafer A., et al. Regional grey matter volume abnormalities in bulimia nervosa and binge-eating disorder. Neuroimage 2010, 50:639-643.
75. Engel S.G., et al. Impulsivity and compulsivity in bulimia nervosa. Int. J. Eat. Disord. 2005, 38:244-251.
76. Fichter M.M., et al. Recurrent overeating: an empirical-comparison of binge-eating disorder, bulimia-nervosa, and obesity. Int. J. Eat. Disord. 1993, 14:1-16.
77. Harrop E.N., Marlatt G.A. The comorbidity of substance use disorders and eating disorders in women: prevalence, etiology, and treatment. Addict. Behav. 2010, 35:392-398.
78. Marsh R., et al. Deficient activity in the neural systems that mediate self-regulatory control in bulimia nervosa. Arch. Gen. Psychiatry 2009, 66:51-63.
79. Steiger H., et al. Implications of compulsive and impulsive traits for serotonin status in women with bulimia nervosa. Psychiatry Res. 2003, 120:219-229.
80. Kaye W., et al. Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am. J. Psychiatry 2004, 161:2215-2221.
81. Harvey A., et al. Cognitive behavioural processes across psychological disorders - a transdiagnostic approach to research and treatment 2004, Oxford University Press.
82. Patel D.D., et al. The neuropsychology of schizo-obsessive subtype of schizophrenia: a new analysis. Psychol. Med. 2010, 40:921-933.
83. Voon V., et al. Impulse-control in Parkinson's disease: recent approaches. Curr. Opin. Neurol. 2011, 24:324-330.
84. Chamberlain S.R., et al. Atomoxetine improved response inhibition in adults with attention-deficit/hyperactivity disorder. Biol. Psychiatry 2007, 62:977-984.
85. Robinson E.S.J., et al. Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 2008, 33:1028-1037.
86. Foa E.B., et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am. J. Psychiatry 2005, 162:151-161.
87. Gunther L.M., et al. Conducting exposure treatment in multiple contexts can prevent relapse. Behav. Res. Ther. 1998, 36:75-91.
88. Myers K.M., Carlezon W.A. Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction. Neurosci. Biobehav. Rev. 2010, 35:285-302.
89. Bouton M.E. Context, ambiguity, and unlearning: sources of relapse after behavioral extinction. Biol. Psychiatry 2002, 52:1546-1549.
90. Whiteside S.P., Lynam D.R. Understanding the role of impulsivity and externalizing psychopathology in alcohol abuse: application of the UPPS impulsive behavior scale. Exp. Clin. Psychopharmacol. 2003, 11:210-217.
91. Thorndike E.L. Animal intelligence: experimental studies 1911, Macmillan.
92. Dickinson A. Actions and habits: the development of behavioural autonomy. Philos. Trans. R. Soc. London Series B: Biol. Sci. 1985, 308:67-78.
93. de Wit S., Dickinson A. Associative theories of goal-directed behaviour: a case for animal-human translational models. Psychol. Res. 2009, 73:463-476.
94. Tricomi E., et al. A specific role for posterior dorsolateral striatum in human habit learning. Eur. J. Neurosci. 2009, 29:2225-2232.
95. Balleine B.W., O'Doherty J. Human and rodent homologies in action control: corticostriatal determinants of goal-directed actions and habitual action. Neuropsychopharmacology 2010, 35:48-69.
96. de Wit S., et al. Differential engagement of the ventromedial prefrontal cortex by goal-directed behavior towards food picture in humans. J. Neurosci. 2009, 29:11330-11338.
97. de Wit H. Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict. Biol. 2009, 14:22-31.
98. Schwabe L., et al. Stress, habits and drug addiction: a psychoneuroendocrinological perspective. Exp. Clin. Psychopharm. 2011, 19:53-63.
99. Williams M.T., et al. Myth of the pure obsessional type in obsessive-compulsive disorder. Depress. Anxiety 2011, 28:495-500.
100. Haber S.N. The primate basal ganglia: parallel and integrative networks. J. Chem. Neuroanat. 2003, 26:317-330.